S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
NASDAQ:VIVE

Viveve Medical (VIVE) Stock Price, News & Analysis

$0.0003
0.00 (0.00%)
(As of 04/19/2024 ET)
Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.00
$0.11
Volume
148 shs
Average Volume
2,716 shs
Market Capitalization
$3,216.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VIVE stock logo

About Viveve Medical Stock (NASDAQ:VIVE)

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

VIVE Stock Price History

VIVE Stock News Headlines

Double your money before lunch?
Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.
VIVE Viveve Medical, Inc.
VIVE - Viveve Medical, Inc.
Viveve Medical, Inc. (VIVE)
Double your money before lunch?
Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.
Why Is Viveve Medical (VIVE) Stock Down 69% Today?
Viveve Medical
See More Headlines
Receive VIVE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viveve Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/11/2021
Today
4/21/2024
Next Earnings (Estimated)
4/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:VIVE
Previous Symbol
OTCMKTS:PLCSD
Employees
47
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$6.43 million

Miscellaneous

Free Float
10,110,000
Market Cap
$3,216.00
Optionable
Not Optionable
Beta
0.08
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Jim B. Robbins (Age 60)
    Senior VP of Finance & Administration and Principal Accounting & Financial Officer
    Comp: $386.94k
  • Ms. Deborah Ann Jorn M.B.A. (Age 66)
    Senior Advisor to the CEO & Director
    Comp: $35k
  • Mr. Martin Kerber P.E.
    Vice President of Research, Development & Operations
  • Ms. Jeannie Swindle
    Senior Director of Corporate Communications
  • Mr. Jeff Sinclair
    Vice President of International Sales
  • Mr. Gary Kaiser
    Vice President of Global Marketing
  • Ms. Lori McMillan
    Vice President of Human Resources
  • Ms. Suzon D. Lommel (Age 66)
    Senior Vice President of Regulatory & Quality Affairs

VIVE Stock Analysis - Frequently Asked Questions

How have VIVE shares performed in 2024?

Viveve Medical's stock was trading at $0.0002 at the start of the year. Since then, VIVE shares have increased by 50.0% and is now trading at $0.0003.
View the best growth stocks for 2024 here
.

When is Viveve Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 22nd 2024.
View our VIVE earnings forecast
.

How were Viveve Medical's earnings last quarter?

Viveve Medical, Inc. (NASDAQ:VIVE) posted its quarterly earnings data on Thursday, November, 11th. The company reported ($0.67) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.58) by $0.09. The firm had revenue of $1.62 million for the quarter. During the same period last year, the business posted ($2.60) earnings per share.

What other stocks do shareholders of Viveve Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), HP (HPQ), Fortive (FTV), Lowe's Companies (LOW), SCYNEXIS (SCYX), Western Digital (WDC), Inovio Pharmaceuticals (INO), Viking Therapeutics (VKTX) and Novavax (NVAX).

When did Viveve Medical IPO?

Viveve Medical (VIVE) raised $13 million in an IPO on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group served as the underwriters for the IPO and Maxim Group was co-manager.

How do I buy shares of Viveve Medical?

Shares of VIVE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:VIVE) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners